NORWOOD, Mass., Sept. 27, 2023 /PRNewswire/ Corbus Pharmaceuticals Holdings, Inc. , a precision oncology company, today announced that an abstract highlighting pre-clinical data on its CRB-601.
NORWOOD, Mass., July 31, 2023 /PRNewswire/ Corbus Pharmaceuticals Holdings, Inc. , a precision oncology company, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will.